The New York v. Purdue Litigation Documents consist of pleadings and trial exhibits from coordinated litigation for the three cases contained in In re Opioid Litigation: County of Suffolk v. Purdue Pharma LP et al., County of Nassau v. Purdue Pharma LP et al., and State of New York v. Purdue Pharma.
The allegations from the combined cases are that manufacturers including Purdue, Teva and Johnson & Johnson; distributors including Amerisource and McKesson; pharmacies including CVS and Walgreens; and individuals including several members of the Sackler family, engaged in deceptive business practices, false advertising, creating a public nuisance, violation of the New York Social Services law, fraud, unjust enrichment, and negligence.
The only defendants that did not settle before trial were Allergan, and Teva and its subsidiaries: Cephalon, Actavis, Anda and Watson Laboratories. On the eve of closing arguments, Allergan settled for $200 million. A verdict was delivered against Teva et al. for creating a public nuisance on December 30, 2021. Teva later settled the claims for $523 million.
The records in this collection were provided to OIDA by the Simmons Hanly Conroy law firm.
The documents consist of emails; distributor agreements between Purdue and Anda, and Purdue and Watson; Suffolk County statistics on overdoses and deaths; marketing plans; sales training materials; compliance and audit reports; correspondence to and from the Drug Enforcement Administration (DEA); and scholarly articles, sales data, suspicious order monitoring (SOM) reports, board meeting minutes, standard operating procedure documentation, settlement agreements, and expert reports (Dr. Craig McCann, Rob Lyerla).
Names frequently appearing in email correspondence are Michael Cochrane, Robert Brown, and Sabrina Solis. The documents show trends in drug distribution and opioid overdoses in New York.
The Opioid Industry Documents Archive (OIDA) received documents with redactions.